151 related articles for article (PubMed ID: 6167110)
1. 5-S-Cysteinyldopa and dopa in serum during treatment with 8-methoxypsoralen and UVA light.
Hansson C; Rorsman H; Rosengren E; Tegner E
Acta Derm Venereol; 1981; 61(3):251-5. PubMed ID: 6167110
[TBL] [Abstract][Full Text] [Related]
2. Observations on PUVA treatment of psoriasis and on 5-S-cysteinyldopa after exposure to UV light.
Tegner E
Acta Derm Venereol Suppl (Stockh); 1983; 107():1-68. PubMed ID: 6410637
[No Abstract] [Full Text] [Related]
3. Urinary excretion of 6-hydroxy-5-methoxyindole-2-carboxylic acid and 5-S-cysteinyldopa during PUVA treatment.
Hansson C; Wirestrand LE; Aronsson A; Rorsman H; Rosengren E
Photodermatol; 1985 Apr; 2(2):52-7. PubMed ID: 3929237
[TBL] [Abstract][Full Text] [Related]
4. 5-S-cysteinyldopa and pigment response to UVA light.
Tegner E; Rorsman H; Rosengren E
Acta Derm Venereol; 1983; 63(1):21-5. PubMed ID: 6191484
[TBL] [Abstract][Full Text] [Related]
5. 5-S-cysteinyldopa excretion after treatment with 8-methoxypsoralen and UVA light.
Agrup G; Hansson C; Rorsman H; Rosengren A-M ; Rosengren E; Tegner E
J Invest Dermatol; 1978 Jan; 70(1):25-6. PubMed ID: 618976
[TBL] [Abstract][Full Text] [Related]
6. The effect of UVB light on serum concentrations of 5-S-cysteinyldopa.
Tegner E; Agrup G; Rosengren E
Acta Derm Venereol; 1983; 63(2):149-52. PubMed ID: 6189331
[No Abstract] [Full Text] [Related]
7. Effects of PUVA on the epidermal melanocyte population in psoriatic patients.
Rosdahl IK; Swanbeck G
Acta Derm Venereol; 1980; 60(1):21-6. PubMed ID: 6153829
[TBL] [Abstract][Full Text] [Related]
8. Dopa and 5-S-cysteinyldopa in the serum of albino, black, and red guinea pigs.
Hansson C; Agrup G; Rorsman H; Rosengren E
Acta Derm Venereol; 1980; 60(2):155-56. PubMed ID: 6155023
[TBL] [Abstract][Full Text] [Related]
9. Urinary 5-S-cysteinyldopa in Parkinsonism after DOPA and carbidopa.
Stewart RM; Miller S; Gunder M
Acta Derm Venereol; 1983; 63(2):97-101. PubMed ID: 6189350
[TBL] [Abstract][Full Text] [Related]
10. 5-S-cysteinyldopa, dopa, and dopamine in the kidney and some other tissues.
Agrup G; Hansson C; Rorsman H; Rosengren E
Acta Derm Venereol; 1980; 60(1):63-4. PubMed ID: 6153836
[TBL] [Abstract][Full Text] [Related]
11. UVB-induced melanocyte proliferation and 5-S-cysteinyldopa excretion in dysplastic nevus syndrome.
Stierner U; Augustsson A; Rosdahl I; Kågedal B; Suurküla M
Photodermatol; 1988 Oct; 5(5):218-23. PubMed ID: 3146749
[TBL] [Abstract][Full Text] [Related]
12. The quantitative determination of 5-S-cysteinyldopa and dopa in normal serum and in serum from patients with malignant melanoma by means of high-pressure liquid chromatography.
Hansson C; Edholm LE; Agrup G; Rorsman H; Rosengren AM; Rosengren E
Clin Chim Acta; 1978 Sep; 88(3):419-27. PubMed ID: 699334
[TBL] [Abstract][Full Text] [Related]
13. Serum 5-S-cysteinyldopa levels in patients with psoriasis undergoing narrowband ultraviolet B phototherapy.
Kikuchi K; Wakamatsu K; Tada Y; Komine M; Ito S; Tamaki K
Clin Exp Dermatol; 2008 Nov; 33(6):750-3. PubMed ID: 18954414
[TBL] [Abstract][Full Text] [Related]
14. Some indolic compounds as markers of the melanocyte activity.
Hansson C
Acta Derm Venereol Suppl (Stockh); 1988; 138():1-60. PubMed ID: 3176811
[TBL] [Abstract][Full Text] [Related]
15. Urinary excretion of 5-S-cysteinyldopa is enhanced by PUVA and is independent of skin type.
Tardy J; Barrois JP; Bendelac A; Leonard F; Triller R; Jardillier JC; Kalis B
Photodermatol; 1987 Aug; 4(4):205-8. PubMed ID: 3124084
[TBL] [Abstract][Full Text] [Related]
16. Plasma 5-S-cysteinyldopa as an index of melanogenesis.
Nimmo JE; Gawkrodger DJ; O'Docherty CS; Going SM; Percy-Robb IW; Hunter JA
Br J Dermatol; 1988 Apr; 118(4):487-95. PubMed ID: 3132198
[TBL] [Abstract][Full Text] [Related]
17. Identification of 5-S-cysteinyldopa by high performance liquid chromatography in biopsies from patients with dysplastic melanocytic nevi.
Halldin MM; Cook WS; Kawashima T; Crutcher WA; Fukuyama K
Cancer Res; 1987 Jan; 47(2):636-8. PubMed ID: 3098416
[TBL] [Abstract][Full Text] [Related]
18. The importance of patient selection for photochemotherapy in psoriasis.
DesGroseilliers JP; Reilly SM; Cullen AE
Can Med Assoc J; 1981 Apr; 124(8):1016-8. PubMed ID: 7260785
[TBL] [Abstract][Full Text] [Related]
19. Effects of PUVA therapy on skin surface lipids: skin surface lipid peroxidation in psoriasis vulgaris and its biological significance.
Hayakawa K; Matsuo I
Tokai J Exp Clin Med; 1986 Nov; 11(5):317-22. PubMed ID: 3672560
[TBL] [Abstract][Full Text] [Related]
20. The pigmentary response to photochemotherapy.
Zaynoun S; Konrad K; Gschnait F; Wolff K
Acta Derm Venereol; 1977; 57(5):431-40. PubMed ID: 73310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]